Almanac A1C

Beyond Calories In, Calories Out: The Carbohydrate-Insulin Model as a Paradigm Shift for Obesity Prevention and Metabolic Health Optimization

Posted

by

dr Leonard Andreas Wiyadharma, BMedSci

Table of Contents
Keywords: , , , , ,

Introduction

The obesity pandemic represents one of the most pressing public health challenges of the 21st century, with global prevalence having tripled since 1975 [1]. Despite intensive research efforts and widespread implementation of dietary guidelines emphasizing caloric restriction and increased physical activity, obesity rates remain at historic highs [2, 3]. This persistent failure suggests fundamental limitations in our current understanding of weight regulation mechanisms.

The traditional energy balance model (EBM) has dominated obesity research and clinical practice for decades, conceptualizing weight gain as simply the result of energy intake exceeding energy expenditure [4]. However, this thermodynamic approach, while mechanistically correct, may overlook crucial biological processes that regulate energy partitioning and metabolic homeostasis [4, 5]. Recent advances in metabolic research have highlighted the importance of hormonal regulation, particularly insulin’s role in energy metabolism, suggesting that the quality and type of macronutrients consumed may be more important than their quantity alone [6, 7].

An alternative paradigm, the carbohydrate-insulin model (CIM) of obesity, proposes a reversal of causal direction, suggesting that hormonal responses to high-glycemic-load carbohydrates promote fat deposition, which subsequently drives increased energy intake and decreased energy expenditure [8, 9]. This model provides a physiological framework for understanding why conventional dietary approaches have shown limited long-term efficacy and offers insights into more effective therapeutic strategies.

The present review synthesizes recent evidence supporting the CIM, examines its implications for our understanding of food intake regulation and hormonal control of metabolism, and explores how this paradigm shift might inform lifestyle interventions for metabolic health, disease prevention, and longevity optimization.

The Carbohydrate-Insulin Model: Mechanistic Framework

Theoretical Foundation

The CIM fundamentally challenges the conventional view that overeating is the primary cause of obesity [4, 8, 10]. Instead, it proposes that dietary composition, particularly carbohydrate quality and glycemic load, initiates a cascade of hormonal changes that promote energy partitioning toward adipose tissue storage, leaving fewer calories available for metabolic processes and thereby driving compensatory increases in food intake [9, 11].

Central to this model is insulin’s dominant anabolic role in energy metabolism. Insulin stimulates glucose uptake into tissues, suppresses release of fatty acids from adipose tissue, inhibits hepatic ketone production, and promotes fat and glycogen deposition [10, 12, 13]. States of increased insulin action, such as insulin-producing tumors or initiation of insulin therapy, are predictably associated with weight gain through metabolic changes rather than solely through reduction in caloric loss [10].

Glycemic Index and Load Effects

The glycemic index (GI) quantifies how rapidly specific foods raise blood glucose levels, with most refined grains, potato products, and added sugars having relatively high GI values [14]. The related measure of glycemic load (GL) accounts for both carbohydrate amount and quality, serving as the best single predictor of postprandial glucose levels and explaining up to 90% of variance in glucose response [15, 16].

High-GL foods produce pronounced postprandial hyperinsulinemia, promoting calorie deposition in fat cells rather than oxidation in lean tissues [17]. This metabolic shift predisposes to weight gain through increased hunger, decreased metabolic rate, or both, creating a self-perpetuating cycle of adiposity and metabolic dysfunction [8–10].

Energy Partitioning Mechanisms

The CIM emphasizes that adipocytes function not as passive storage sites but as active metabolic organs that respond to hormonal signals [18–20]. Insulin’s anti-lipolytic effects suppress the release of fatty acids and glycerol from adipose tissue, directly linking fat cell metabolism to systemic energy availability [12, 21, 22].

Recent research has demonstrated that insulin-stimulated glucose uptake by adipocytes has systemic metabolic consequences that extend beyond the amount of glucose disposed of by fat tissue alone [23, 24]. Deletion of glucose transporter 4 (GLUT4) from adipocytes causes hyperglycemia and peripheral insulin resistance without altering adipocyte number or size, highlighting the central role of adipose tissue in whole-body glucose homeostasis [24–26].

Comparison to Traditional Energy Balance Model

Fundamental Differences in Causal Direction

The EBM conceptualizes obesity as a disorder of energy balance, restating thermodynamic principles without considering the biological mechanisms that promote weight gain [8, 27]. While acknowledging the role of “complex endocrine, metabolic, and nervous system signals,” the EBM maintains that overeating (energy intake > expenditure) is the primary cause of obesity [4, 28].

In contrast, the CIM proposes that increasing adiposity causes overeating to compensate for calories sequestered in fat tissue [4, 9]. This reversal of causal direction has profound implications for treatment approaches, suggesting that calorie restriction may represent symptomatic treatment that could exacerbate underlying metabolic dysfunction by further restricting energy availability and triggering starvation responses [9, 29, 30].

Limitations of Pure Thermodynamic Approaches

Recent analytical work has identified serious inconsistencies in the energy balance theory, demonstrating that weight stability can coexist with persistent energy imbalance [31]. This finding challenges the fundamental assumption that energy balance automatically leads to weight stability, suggesting that more complex metabolic processes govern body weight regulation.

Moreover, practical limitations in measuring energy balance components highlight the inadequacy of simple caloric approaches. The combined error in assessing energy imbalance can easily reach 1000 kcal/day in free-living individuals, preventing accurate evaluation of small but metabolically significant interventions [30, 32].

Effects on Food Intake Regulation and Hormonal Responses

Appetite Regulation and Satiety Signals

The CIM provides a framework for understanding how different macronutrients affect appetite regulation beyond their caloric content. High-GL carbohydrates produce rapid glucose and insulin spikes followed by reactive hypoglycemia, potentially triggering increased hunger and food-seeking behavior.

This contrasts with the satiating effects of protein and fat, which produce more sustained energy release without dramatic fluctuations in blood glucose and insulin levels [33, 34]. The differential effects of macronutrients on hunger hormones such as ghrelin and leptin may partially explain why isocaloric diets with varying carbohydrate content produce different outcomes for weight management and metabolic health [35, 36].

Leptin and Ghrelin Dynamics

Recent research has clarified the complex interplay between insulin, leptin, and ghrelin in energy homeostasis. Leptin, produced by adipocytes, signals energy sufficiency to the hypothalamus and promotes satiety, while ghrelin, primarily secreted by the stomach, stimulates appetite before meals [37, 38].

The CIM suggests that chronic hyperinsulinemia may disrupt normal leptin signaling, leading to central leptin resistance despite adequate or excessive energy stores [39–41]. This disruption may explain why individuals with obesity often report persistent hunger despite consuming adequate calories, supporting the model’s emphasis on hormonal rather than purely caloric factors in weight regulation [42, 43].

Insulin Resistance and Metabolic Dysfunction

Insulin resistance represents a critical component of the CIM, affecting approximately 40% of US adults aged 18-44 based on recent analyses [44, 45]. The development of insulin resistance creates a vicious cycle where higher insulin levels are required to maintain glucose homeostasis, further promoting fat storage and metabolic dysfunction [46, 47].

Clinical evidence demonstrates that insulin resistance precedes type 2 diabetes development by several years [44, 48, 49], accompanied by progressive deterioration in metabolic flexibility – the ability to efficiently switch between glucose and fat oxidation based on substrate availability [50–52]. This loss of metabolic flexibility may represent a key mechanism linking dietary carbohydrate quality to long-term metabolic health outcomes [53, 54].

Implications for Healthy Living and Metabolic Lifestyle

Dietary Composition vs. Caloric Restriction

The CIM suggests that focusing on dietary composition, particularly carbohydrate quality and glycemic load, may be more effective than caloric restriction alone for achieving sustainable weight loss and metabolic health [10, 55]. Recent meta-analysis report greater weight loss with reduced-glycemic load compared to low-fat diets, though compliance remains a challenge in behavioral trials [56].

Clinical evidence supports the metabolic advantages of low-carbohydrate approaches. A recent systematic review and meta-analysis of randomized controlled trials in overweight or obese patients with type 2 diabetes demonstrated that low-carbohydrate diets significantly improved HbA1c levels, fasting plasma glucose, triglycerides, and HDL cholesterol compared to control diets [57, 58].

Metabolic Flexibility and Substrate Utilization

Low-carbohydrate, high-fat (LCHF) dietary approaches have been shown to dramatically improve metabolic flexibility by enhancing fat oxidation capacity while maintaining the ability to utilize carbohydrates when needed. Recent research demonstrates that LCHF-adapted athletes can derive 50% or more of their energy requirements from fat at exercise intensities up to 90% VO2max, challenging traditional concepts of “carbohydrate dependence” for high-intensity performance [59, 60].

This enhanced metabolic flexibility may confer significant health advantages by reducing dependence on frequent carbohydrate intake, stabilizing blood glucose levels, and improving insulin sensitivity. Studies using slowly digestible starches have shown superior metabolic flexibility compared to diets high in rapidly digestible carbohydrates, supporting the CIM’s emphasis on carbohydrate quality [59, 60].

Intermittent Fasting and Time-Restricted Eating

Emerging research on chrononutrition supports CIM principles by demonstrating that meal timing significantly affects metabolic outcomes [61, 62]. Early time-restricted eating, where food intake is confined to morning or early afternoon hours, has shown superior benefits for weight control, glycemic regulation, and insulin sensitivity compared to later eating patterns [63–65].

A recent clinical trial demonstrate that 4:3 intermittent fasting (eating freely four days per week with three days of calorie restriction) produces greater weight loss than daily caloric restriction, with participants losing 7.6% versus 5% of body weight at one year [66]. This finding supports the CIM’s emphasis on hormonal rather than purely caloric mechanisms of weight regulation.

Circadian Rhythm Optimization

The CIM’s emphasis on insulin sensitivity aligns with circadian rhythm research showing that glucose tolerance and insulin sensitivity follow daily patterns, with peak sensitivity occurring in the morning [67–69]. Consuming meals during periods of naturally high insulin sensitivity may optimize metabolic outcomes and reduce the tendency toward fat storage [62, 70].

Studies demonstrate that consuming meals later in the day is associated with elevated prevalence of metabolic disorders, while early breakfast and earlier dinner improve glucose levels and substrate oxidation [70–72]. This temporal component of metabolism supports CIM principles by highlighting how the timing of carbohydrate intake interacts with endogenous hormonal rhythms [67].

Disease Prevention and Longevity Implications

Cardiovascular Disease Prevention

Low-carbohydrate dietary approaches consistent with CIM principles have demonstrated significant cardiovascular benefits in recent clinical trials [73–75]. A 12-week lifestyle intervention combining Mediterranean eating patterns, omega-3 supplementation, and high-intensity exercise resulted in significant reductions in triglycerides, blood pressure, fasting insulin, and inflammatory markers [76].

The CIM’s emphasis on reducing postprandial glucose excursions may be particularly relevant for cardiovascular disease prevention, as glucose variability has been identified as an independent risk factor for cardiovascular events [77–79]. Personalized dietary approaches targeting postprandial glycemic responses show promise for improving metabolic outcomes beyond traditional low-fat dietary recommendations [80–82].

Type 2 Diabetes Management and Remission

Recent real-world evidence demonstrates remarkable potential for diabetes remission using low-carbohydrate approaches aligned with CIM principles [80, 83]. A primary care study reported 93% remission of prediabetes and 46% drug-free remission of type 2 diabetes over six years using standard 10-minute appointments focused on carbohydrate reduction [84].

These outcomes far exceed those typically achieved with conventional dietary approaches emphasizing caloric restriction and fat reduction [83, 84]. The CIM provides a mechanistic explanation for this superior efficacy by addressing the underlying hormonal dysregulation rather than merely managing symptoms through medication [85, 86].

Inflammation and Chronic Disease

The CIM’s focus on reducing insulin resistance and improving metabolic flexibility may have broad implications for chronic disease prevention through anti-inflammatory effects [87, 88]. Research demonstrate that high-fiber, plant-based dietary interventions (which typically have lower glycemic loads) consistently reduce inflammatory markers and improve microbiome diversity compared to other dietary approaches [89].

Recent research on anti-inflammatory diets shows particular promise for improving physical quality of life in adults with chronic diseases. These interventions, which emphasize minimally processed foods and limit refined carbohydrates, align closely with CIM principles while demonstrating measurable benefits for disease management [88].

Longevity and Healthy Aging

The CIM’s emphasis on metabolic health optimization may contribute to healthy longevity through multiple mechanisms. Recent analysis of large cohort studies demonstrates that combining healthy dietary patterns (characterized by nutrient-rich plant foods and limited processed foods) with other lifestyle factors can extend disease-free life expectancy by 8-10 years [90].

Maintaining healthy weight throughout life, which the CIM suggests is best achieved through hormonal optimization rather than chronic caloric restriction, appears pivotal for healthy aging and longevity [90, 91]. This approach may prove more sustainable and effective than traditional weight management strategies, particularly in today’s obesogenic food environment.

Clinical Evidence and Research Directions

Ketogenic Interventions and Metabolic Health

Recent clinical research on ketogenic diets provides strong support for CIM principles. A controlled study demonstrated that a 3-week ketogenic diet significantly increased skeletal muscle insulin sensitivity in individuals with obesity, independent of caloric restriction [92]. This finding supports the CIM’s contention that carbohydrate restriction improves metabolic function through hormonal mechanisms rather than simple energy balance [92].

Ketogenic metabolic therapy is showing promise in various clinical applications, from obesity management to potential cancer treatment, by targeting the metabolic inflexibility characteristic of many chronic diseases [93, 94]. The ability of ketogenic approaches to rapidly improve insulin sensitivity while maintaining or increasing lean body mass challenges conventional assumptions about the necessity of carbohydrates for optimal health [95, 96].

Personalized Nutrition Approaches

The CIM framework supports the development of personalized nutrition strategies based on individual metabolic responses to different foods. Recent trials comparing personalized diets targeting reduced postprandial glycemic responses to standardized low-fat diets show promise, though results have been mixed regarding weight loss outcomes [97, 98].

Future research should focus on identifying biomarkers and genetic factors that predict individual responses to different macronutrient compositions, allowing for more targeted application of CIM principles. Cultural context significantly influences dietary adherence and metabolic outcomes, necessitating adaptation of CIM-based interventions to diverse populations.

Future Research Directions and Clinical Applications

Mechanistic Research Needs

Despite growing evidence supporting the CIM, several mechanistic questions remain. Further research is needed to fully elucidate the complex interactions between insulin, other hormones, and energy partitioning in different populations and metabolic states. Long-term studies examining the sustainability and safety of low-carbohydrate approaches are essential for establishing clinical guidelines.

The role of food processing and ultra-processed foods in CIM pathways requires additional investigation. Recent research suggests that highly processed foods may disrupt normal satiety signaling and promote overconsumption through mechanisms that align with CIM predictions [99, 100].

Clinical Implementation Strategies

Successful clinical implementation of CIM-based approaches requires addressing practical barriers including patient education, healthcare provider training, and integration with existing medical care. Real-world evidence suggests that structured, evidence-based education delivered through standard clinical encounters can achieve remarkable outcomes when properly implemented.

Digital health technologies and continuous glucose monitoring may enhance CIM-based interventions by providing real-time feedback on the metabolic effects of different foods and eating patterns. These tools could help individuals optimize their dietary choices based on personal glucose responses rather than population-based recommendations.

Conclusion

The carbohydrate-insulin model of obesity represents a paradigm shift in our understanding of weight regulation and metabolic health. By emphasizing the primacy of hormonal regulation over simple energy balance, the CIM provides a mechanistic framework for understanding why conventional dietary approaches have shown limited long-term efficacy.

The model’s core proposition – that dietary carbohydrate quality and glycemic load drive hormonal changes that promote fat storage and metabolic dysfunction – is supported by growing clinical evidence and offers more promising therapeutic targets than traditional caloric restriction approaches. The CIM’s emphasis on improving insulin sensitivity, enhancing metabolic flexibility, and optimizing hormonal responses to food intake aligns with emerging research on personalized nutrition, chrononutrition, and metabolic health optimization.

For clinical practice, the CIM suggests that focusing on carbohydrate quality, meal timing, and metabolic flexibility may be more effective than traditional approaches emphasizing caloric restriction and fat reduction. This paradigm shift has profound implications for obesity management, diabetes prevention and treatment, and broader chronic disease prevention strategies.

The integration of CIM principles with lifestyle medicine approaches – including stress management, sleep optimization, and circadian rhythm alignment – may offer the most comprehensive strategy for achieving sustainable metabolic health improvements and supporting healthy longevity. As our understanding of these complex metabolic interactions continues to evolve, the CIM provides a valuable framework for developing more effective, physiologically-based approaches to metabolic health optimization.

Future research should focus on personalizing CIM-based interventions, establishing long-term safety and efficacy data, and developing practical implementation strategies for diverse populations. The ultimate goal is to translate these mechanistic insights into effective, sustainable approaches that can address the global obesity pandemic and its associated metabolic complications while supporting optimal health and longevity throughout the lifespan.

References

  1. Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism 2022; 133: 155217.
  2. Koliaki C, Dalamaga M, Liatis S. Update on the Obesity Epidemic: After the Sudden Rise, Is the Upward Trajectory Beginning to Flatten? Curr Obes Rep 2023; 12: 514–527.
  3. Chao AM, Quigley KM, Wadden TA. Dietary interventions for obesity: clinical and mechanistic findings. J Clin Invest; 131. Epub ahead of print 4 January 2021. DOI: 10.1172/JCI140065.
  4. Ludwig DS, Apovian CM, Aronne LJ, et al. Competing paradigms of obesity pathogenesis: energy balance versus carbohydrate-insulin models. Eur J Clin Nutr 2022; 76: 1209–1221.
  5. Hall KD, Heymsfield SB, Kemnitz JW, et al. Energy balance and its components: implications for body weight regulation. Am J Clin Nutr 2012; 95: 989–94.
  6. Tao Z, Cheng Z. Hormonal regulation of metabolism-recent lessons learned from insulin and estrogen. Clin Sci (Lond) 2023; 137: 415–434.
  7. Dos Santos KC, Olofsson C, Cunha JPMCM, et al. The impact of macronutrient composition on metabolic regulation: An Islet-Centric view. Acta Physiol (Oxf) 2022; 236: e13884.
  8. Ludwig DS, Aronne LJ, Astrup A, et al. The carbohydrate-insulin model: a physiological perspective on the obesity pandemic. Am J Clin Nutr 2021; 114: 1873–1885.
  9. Ludwig DS. Carbohydrate-insulin model: does the conventional view of obesity reverse cause and effect? Philosophical Transactions of the Royal Society B: Biological Sciences; 378. Epub ahead of print 23 October 2023. DOI: 10.1098/rstb.2022.0211.
  10. Ludwig DS, Ebbeling CB. The Carbohydrate-Insulin Model of Obesity: Beyond ‘Calories In, Calories Out’. JAMA Intern Med 2018; 178: 1098–1103.
  11. Sievenpiper JL. Low-carbohydrate diets and cardiometabolic health: the importance of carbohydrate quality over quantity. Nutr Rev 2020; 78: 69–77.
  12. Carpentier AC. 100th anniversary of the discovery of insulin perspective: insulin and adipose tissue fatty acid metabolism. American Journal of Physiology-Endocrinology and Metabolism 2021; 320: E653–E670.
  13. Sepulveda MAC, Joy N V, Vargas E. Biochemistry, Insulin Metabolic Effects. StatPearls Publishing, https://www.ncbi.nlm.nih.gov/books/NBK525983/ (2022, accessed 17 September 2025).
  14. Mousavi SM, Gu X, Imamura F, et al. Total and specific potato intake and risk of type 2 diabetes: results from three US cohort studies and a substitution meta-analysis of prospective cohorts. BMJ 2025; 390: e082121.
  15. Brand-Miller JC, Thomas M, Swan V, et al. Physiological Validation of the Concept of Glycemic Load in Lean Young Adults. J Nutr 2003; 133: 2728–2732.
  16. Lee H, Um M, Nam K, et al. Development of a Prediction Model to Estimate the Glycemic Load of Ready-to-Eat Meals. Foods; 10. Epub ahead of print 29 October 2021. DOI: 10.3390/foods10112626.
  17. Brand-Miller JC, Holt SH, Pawlak DB, et al. Glycemic index and obesity. Am J Clin Nutr 2002; 76: 281S-285S.
  18. Kershaw EE, Flier JS. Adipose Tissue as an Endocrine Organ. J Clin Endocrinol Metab 2004; 89: 2548–2556.
  19. Luo L, Liu M. Adipose tissue in control of metabolism. J Endocrinol 2016; 231: R77–R99.
  20. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006; 83: 461S-465S.
  21. Zhao J, Wu Y, Rong X, et al. Anti-Lipolysis Induced by Insulin in Diverse Pathophysiologic Conditions of Adipose Tissue. Diabetes Metab Syndr Obes 2020; 13: 1575–1585.
  22. Edwards M, Mohiuddin SS. Biochemistry, Lipolysis. StatPearls Publishing, https://www.ncbi.nlm.nih.gov/books/NBK560564/ (2023, accessed 17 September 2025).
  23. Kahn BB. Adipose Tissue, Inter-Organ Communication, and the Path to Type 2 Diabetes: The 2016 Banting Medal for Scientific Achievement Lecture. Diabetes 2019; 68: 3–14.
  24. Santoro A, McGraw TE, Kahn BB. Insulin action in adipocytes, adipose remodeling, and systemic effects. Cell Metab 2021; 33: 748–757.
  25. Carvalho E, Kotani K, Peroni OD, et al. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. American Journal of Physiology-Endocrinology and Metabolism 2005; 289: E551–E561.
  26. Atkinson BJ, Griesel BA, King CD, et al. Moderate GLUT4 Overexpression Improves Insulin Sensitivity and Fasting Triglyceridemia in High-Fat Diet–Fed Transgenic Mice. Diabetes 2013; 62: 2249–2258.
  27. Heindel JJ, Lustig RH, Howard S, et al. Obesogens: a unifying theory for the global rise in obesity. Int J Obes 2024; 48: 449–460.
  28. Hall KD, Farooqi IS, Friedman JM, et al. The energy balance model of obesity: beyond calories in, calories out. Am J Clin Nutr 2022; 115: 1243–1254.
  29. Hofer SJ, Carmona‐Gutierrez D, Mueller MI, et al. The ups and downs of caloric restriction and fasting: from molecular effects to clinical application. EMBO Mol Med; 14. Epub ahead of print 11 January 2022. DOI: 10.15252/emmm.202114418.
  30. Most J, Redman LM. Impact of calorie restriction on energy metabolism in humans. Exp Gerontol 2020; 133: 110875.
  31. Arencibia-Albite F. Serious analytical inconsistencies challenge the validity of the energy balance theory. Heliyon 2020; 6: e04204.
  32. Ries D, Carriquiry A, Shook R. Modeling energy balance while correcting for measurement error via free knot splines. PLoS One 2018; 13: e0201892.
  33. James Stubbs R, Horgan G, Robinson E, et al. Diet composition and energy intake in humans. Philosophical Transactions of the Royal Society B: Biological Sciences; 378. Epub ahead of print 23 October 2023. DOI: 10.1098/rstb.2022.0449.
  34. Carreiro AL, Dhillon J, Gordon S, et al. The Macronutrients, Appetite, and Energy Intake. Annu Rev Nutr 2016; 36: 73–103.
  35. Adamska-Patruno E, Ostrowska L, Goscik J, et al. The relationship between the leptin/ghrelin ratio and meals with various macronutrient contents in men with different nutritional status: a randomized crossover study. Nutr J 2018; 17: 118.
  36. Ebbeling CB, Feldman HA, Klein GL, et al. Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial. BMJ 2020; m4264.
  37. Vijayashankar U, Ramashetty R, Rajeshekara M, et al. Leptin and ghrelin dynamics: unraveling their influence on food intake, energy balance, and the pathophysiology of type 2 diabetes mellitus. J Diabetes Metab Disord 2024; 23: 427–440.
  38. Chabot F, Caron A, Laplante M, et al. Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance. World J Diabetes 2014; 5: 328–41.
  39. Genchi VA, D’Oria R, Palma G, et al. Impaired Leptin Signalling in Obesity: Is Leptin a New Thermolipokine? Int J Mol Sci; 22. Epub ahead of print 16 June 2021. DOI: 10.3390/ijms22126445.
  40. Gupta A, Beg M, Kumar D, et al. Chronic hyper-leptinemia induces insulin signaling disruption in adipocytes: Implications of NOS2. Free Radic Biol Med 2017; 112: 93–108.
  41. Nazarians-Armavil A, Menchella JA, Belsham DD. Cellular insulin resistance disrupts leptin-mediated control of neuronal signaling and transcription. Mol Endocrinol 2013; 27: 990–1003.
  42. Greenway FL. Physiological adaptations to weight loss and factors favouring weight regain. Int J Obes 2015; 39: 1188–1196.
  43. Azemi AK, Mutalub YB, Abdulwahab M, et al. Obesity-driven hunger: From pathophysiology to intervention. Obes Med 2025; 54: 100588.
  44. Freeman AM, Acevedo LA, Pennings N. Insulin Resistance. StatPearls Publishing, https://www.ncbi.nlm.nih.gov/books/NBK507839/ (2023, accessed 17 September 2025).
  45. Parcha V, Heindl B, Kalra R, et al. Insulin Resistance and Cardiometabolic Risk Profile Among Nondiabetic American Young Adults: Insights From NHANES. J Clin Endocrinol Metab 2022; 107: e25–e37.
  46. Wilcox G. Insulin and Insulin Resistance. Clin Biochem Rev 2005; 26: 19–39.
  47. Li M, Chi X, Wang Y, et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther 2022; 7: 216.
  48. Burrows R, Correa‐Burrows P, Bunout D, et al. Obesity and impairment of pancreatic β‐cell function in early adulthood, independent of obesity age of onset: The Santiago Longitudinal Study. Diabetes Metab Res Rev; 37. Epub ahead of print 4 February 2021. DOI: 10.1002/dmrr.3371.
  49. Weyer C, Bogardus C, Mott DM, et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Journal of Clinical Investigation 1999; 104: 787–794.
  50. Galgani JE, Moro C, Ravussin E. Metabolic flexibility and insulin resistance. American Journal of Physiology-Endocrinology and Metabolism 2008; 295: E1009–E1017.
  51. Goodpaster BH, Sparks LM. Metabolic Flexibility in Health and Disease. Cell Metab 2017; 25: 1027–1036.
  52. Smith RL, Soeters MR, Wüst RCI, et al. Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease. Endocr Rev 2018; 39: 489–517.
  53. Bacha F, Bartz SK, Puyau M, et al. Metabolic flexibility across the spectrum of glycemic regulation in youth. JCI Insight; 6. Epub ahead of print 22 February 2021. DOI: 10.1172/jci.insight.146000.
  54. Vieira-Lara MA, Dommerholt MB, Zhang W, et al. Age-related susceptibility to insulin resistance arises from a combination of CPT1B decline and lipid overload. BMC Biol 2021; 19: 154.
  55. Fabricatore AN, Wadden TA, Ebbeling CB, et al. Targeting dietary fat or glycemic load in the treatment of obesity and type 2 diabetes: a randomized controlled trial. Diabetes Res Clin Pract 2011; 92: 37–45.
  56. Zafar MI, Mills KE, Zheng J, et al. Low glycaemic index diets as an intervention for obesity: a systematic review and meta‐analysis. Obesity Reviews 2019; 20: 290–315.
  57. Apekey TA, Maynard MJ, Kittana M, et al. Comparison of the Effectiveness of Low Carbohydrate Versus Low Fat Diets, in Type 2 Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 2022; 14: 4391.
  58. Tian W, Cao S, Guan Y, et al. The effects of low-carbohydrate diet on glucose and lipid metabolism in overweight or obese patients with T2DM: a meta-analysis of randomized controlled trials. Front Nutr; 11. Epub ahead of print 6 January 2025. DOI: 10.3389/fnut.2024.1516086.
  59. Noakes TD, Prins PJ, Volek JS, et al. Low carbohydrate high fat ketogenic diets on the exercise crossover point and glucose homeostasis. Front Physiol; 14. Epub ahead of print 28 March 2023. DOI: 10.3389/fphys.2023.1150265.
  60. Prins PJ, Noakes TD, Buxton JD, et al. High fat diet improves metabolic flexibility during progressive exercise to exhaustion (VO2max testing) and during 5 km running time trials. Biol Sport 2023; 40: 465–475.
  61. Reytor-González C, Simancas-Racines D, Román-Galeano NM, et al. Chrononutrition and Energy Balance: How Meal Timing and Circadian Rhythms Shape Weight Regulation and Metabolic Health. Nutrients 2025; 17: 2135.
  62. Peters B, Vahlhaus J, Pivovarova-Ramich O. Meal timing and its role in obesity and associated diseases. Front Endocrinol (Lausanne); 15. Epub ahead of print 22 March 2024. DOI: 10.3389/fendo.2024.1359772.
  63. Yu Z, Ueda T. Early Time-Restricted Eating Improves Weight Loss While Preserving Muscle: An 8-Week Trial in Young Women. Nutrients 2025; 17: 1022.
  64. Sutton EF, Beyl R, Early KS, et al. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab 2018; 27: 1212-1221.e3.
  65. Bitsanis D, Giannakou K, Hadjimbei E, et al. The Effect of Early Time-Restricted Feeding on Glycemic Profile in Adults: A Systematic Review of Interventional Studies. Review of Diabetic Studies 2022; 18: 10–19.
  66. Catenacci VA, Ostendorf DM, Pan Z, et al. The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months. Ann Intern Med 2025; 178: 634–644.
  67. Morris CJ, Yang JN, Garcia JI, et al. Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans. Proceedings of the National Academy of Sciences; 112. Epub ahead of print 28 April 2015. DOI: 10.1073/pnas.1418955112.
  68. Mason IC, Qian J, Adler GK, et al. Impact of circadian disruption on glucose metabolism: implications for type 2 diabetes. Diabetologia 2020; 63: 462–472.
  69. Poggiogalle E, Jamshed H, Peterson CM. Circadian regulation of glucose, lipid, and energy metabolism in humans. Metabolism 2018; 84: 11–27.
  70. BaHammam AS, Pirzada A. Timing Matters: The Interplay between Early Mealtime, Circadian Rhythms, Gene Expression, Circadian Hormones, and Metabolism-A Narrative Review. Clocks Sleep 2023; 5: 507–535.
  71. Díaz-Rizzolo DA, Santos Baez LS, Popp CJ, et al. Late eating is associated with poor glucose tolerance, independent of body weight, fat mass, energy intake and diet composition in prediabetes or early onset type 2 diabetes. Nutr Diabetes 2024; 14: 90.
  72. Nakamura K, Tajiri E, Hatamoto Y, et al. Eating Dinner Early Improves 24-h Blood Glucose Levels and Boosts Lipid Metabolism after Breakfast the Next Day: A Randomized Cross-Over Trial. Nutrients; 13. Epub ahead of print 15 July 2021. DOI: 10.3390/nu13072424.
  73. Hamer O. Low-carbohydrate diets for reducing cardiovascular risk and supporting weight loss in adults: a synthesis of systematic reviews. British Journal of Cardiac Nursing 2023; 18: 1–15.
  74. Pi S, Zhang S, Zhang J, et al. Low-carbohydrate diets reduce cardiovascular risk factor levels in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials. Front Nutr; 12. Epub ahead of print 26 August 2025. DOI: 10.3389/fnut.2025.1626352.
  75. Hu T, Yao L, Reynolds K, et al. The Effects of a Low-Carbohydrate Diet vs. a Low-Fat Diet on Novel Cardiovascular Risk Factors: A Randomized Controlled Trial. Nutrients 2015; 7: 7978–7994.
  76. Dunn S, Boutcher SH, Freund J, et al. The effect of a lifestyle intervention on metabolic health in young women. Diabetes Metab Syndr Obes 2014; 437.
  77. Cavalot F, Pagliarino A, Valle M, et al. Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up. Diabetes Care 2011; 34: 2237–2243.
  78. Hanssen NMJ, Kraakman MJ, Flynn MC, et al. Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes? Front Cardiovasc Med; 7. Epub ahead of print 18 September 2020. DOI: 10.3389/fcvm.2020.570553.
  79. Liang S, Yin H, Wei C, et al. Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis. J Diabetes Metab Disord 2017; 16: 45.
  80. Bermingham KM, Linenberg I, Polidori L, et al. Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial. Nat Med 2024; 30: 1888–1897.
  81. Ben-Yacov O, Godneva A, Rein M, et al. Personalized Postprandial Glucose Response–Targeting Diet Versus Mediterranean Diet for Glycemic Control in Prediabetes. Diabetes Care 2021; 44: 1980–1991.
  82. Mendes-Soares H, Raveh-Sadka T, Azulay S, et al. Assessment of a Personalized Approach to Predicting Postprandial Glycemic Responses to Food Among Individuals Without Diabetes. JAMA Netw Open 2019; 2: e188102.
  83. Unwin D, Delon C, Unwin J, et al. What predicts drug-free type 2 diabetes remission? Insights from an 8-year general practice service evaluation of a lower carbohydrate diet with weight loss. BMJ Nutr Prev Health 2023; 6: 46–55.
  84. Unwin D, Khalid AA, Unwin J, et al. Insights from a general practice service evaluation supporting a lower carbohydrate diet in patients with type 2 diabetes mellitus and prediabetes: a secondary analysis of routine clinic data including HbA1c, weight and prescribing over 6 years. BMJ Nutr Prev Health 2020; 3: 285–294.
  85. Mongkolsucharitkul P, Surawit A, Pimsen A, et al. Effectiveness of low-carbohydrate diets on type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials in Eastern vs. Western populations. Diabetes Res Clin Pract 2025; 229: 112464.
  86. Wheatley SD, Deakin TA, Arjomandkhah NC, et al. Low Carbohydrate Dietary Approaches for People With Type 2 Diabetes-A Narrative Review. Front Nutr 2021; 8: 687658.
  87. Yu X, Pu H, Voss M. Overview of anti-inflammatory diets and their promising effects on non-communicable diseases. British Journal of Nutrition 2024; 132: 898–918.
  88. Law L, Heerey JJ, Devlin BL, et al. Effect of anti-inflammatory diets on health-related quality of life in adults with chronic disease: a systematic review and meta-analysis. BMJ Nutr Prev Health 2025; 8: 314–326.
  89. Wastyk HC, Fragiadakis GK, Perelman D, et al. Gut-microbiota-targeted diets modulate human immune status. Cell 2021; 184: 4137-4153.e14.
  90. Hu FB. Diet strategies for promoting healthy aging and longevity: An epidemiological perspective. J Intern Med 2024; 295: 508–531.
  91. Tessier A-J, Wang F, Korat AA, et al. Optimal dietary patterns for healthy aging. Nat Med 2025; 31: 1644–1652.
  92. Luong TV, Pedersen MGB, Abild CB, et al. A 3-Week Ketogenic Diet Increases Skeletal Muscle Insulin Sensitivity in Individuals With Obesity: A Randomized Controlled Crossover Trial. Diabetes 2024; 73: 1631–1640.
  93. Alparslan Z, Kızılca B. METABOLIC PERSPECTIVE OF CANCER: KETOGENIC DIET AND METABOLISM ANTAGONISTS. TURKISH MEDICAL STUDENT JOURNAL 2023; 10: 99–104.
  94. Talib WH, Mahmod AI, Kamal A, et al. Ketogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities. Curr Issues Mol Biol 2021; 43: 558–589.
  95. Zhu H, Bi D, Zhang Y, et al. Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduct Target Ther 2022; 7: 11.
  96. Baylie T, Ayelgn T, Tiruneh M, et al. Effect of Ketogenic Diet on Obesity and Other Metabolic Disorders: Narrative Review. Diabetes, Metabolic Syndrome and Obesity 2024; Volume 17: 1391–1401.
  97. Zeevi D, Korem T, Zmora N, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell 2015; 163: 1079–1094.
  98. Popp CJ, Hu L, Kharmats AY, et al. Effect of a Personalized Diet to Reduce Postprandial Glycemic Response vs a Low-fat Diet on Weight Loss in Adults With Abnormal Glucose Metabolism and Obesity. JAMA Netw Open 2022; 5: e2233760.
  99. Juul F, Vaidean G, Parekh N. Ultra-processed Foods and Cardiovascular Diseases: Potential Mechanisms of Action. Advances in Nutrition 2021; 12: 1673–1680.
  100. Poti JM, Braga B, Qin B. Ultra-processed Food Intake and Obesity: What Really Matters for Health—Processing or Nutrient Content? Curr Obes Rep 2017; 6: 420–431.